美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
71335-1391-7	71335-1391	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20211228	N/A	ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500 mg/1	14 TABLET in 1 BOTTLE (71335-1391-7)
71335-1391-8	71335-1391	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20211228	N/A	ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500 mg/1	100 TABLET in 1 BOTTLE (71335-1391-8)
50228-466-01	50228-466	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20190626	N/A	ANDA	ANDA078420	ScieGen Pharmaceuticals Inc	NABUMETONE	750 mg/1	100 TABLET in 1 BOTTLE (50228-466-01)
60760-368-15	60760-368	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20191021	N/A	ANDA	ANDA078420	St. Mary's Medical Park Pharmacy	NABUMETONE	500 mg/1	15 TABLET in 1 BOTTLE, PLASTIC (60760-368-15)
60760-368-60	60760-368	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20200303	N/A	ANDA	ANDA078420	St. Mary's Medical Park Pharmacy	NABUMETONE	500 mg/1	60 TABLET in 1 BOTTLE, PLASTIC (60760-368-60)
50090-6167-0	50090-6167	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20221013	N/A	ANDA	ANDA078420	A-S Medication Solutions	NABUMETONE	750 mg/1	30 TABLET in 1 BOTTLE (50090-6167-0)
50090-6167-2	50090-6167	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20221013	N/A	ANDA	ANDA078420	A-S Medication Solutions	NABUMETONE	750 mg/1	14 TABLET in 1 BOTTLE (50090-6167-2)
50090-6167-3	50090-6167	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20221013	N/A	ANDA	ANDA078420	A-S Medication Solutions	NABUMETONE	750 mg/1	60 TABLET in 1 BOTTLE (50090-6167-3)
50090-6167-4	50090-6167	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20221013	N/A	ANDA	ANDA078420	A-S Medication Solutions	NABUMETONE	750 mg/1	20 TABLET in 1 BOTTLE (50090-6167-4)
63629-8509-1	63629-8509	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20190626	N/A	ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	750 mg/1	500 TABLET in 1 BOTTLE (63629-8509-1)
71335-2292-1	71335-2292	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20231201	N/A	ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500 mg/1	500 TABLET in 1 BOTTLE (71335-2292-1)
71205-978-00	71205-978	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20200507	N/A	ANDA	ANDA078420	Proficient Rx LP	NABUMETONE	750 mg/1	100 TABLET in 1 BOTTLE, PLASTIC (71205-978-00)
71205-978-30	71205-978	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20200507	N/A	ANDA	ANDA078420	Proficient Rx LP	NABUMETONE	750 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (71205-978-30)
51655-446-20	51655-446	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20201002	N/A	ANDA	ANDA078420	Northwind Health Company, LLC	NABUMETONE	500 mg/1	20 TABLET in 1 BOTTLE, PLASTIC (51655-446-20)
51655-446-25	51655-446	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20220504	N/A	ANDA	ANDA078420	Northwind Health Company, LLC	NABUMETONE	500 mg/1	60 TABLET in 1 BOTTLE, PLASTIC (51655-446-25)
51655-446-52	51655-446	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20201223	N/A	ANDA	ANDA078420	Northwind Health Company, LLC	NABUMETONE	500 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (51655-446-52)
51655-446-84	51655-446	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20220128	N/A	ANDA	ANDA078420	Northwind Health Company, LLC	NABUMETONE	500 mg/1	14 TABLET in 1 BOTTLE, PLASTIC (51655-446-84)
69367-242-01	69367-242	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20190925	N/A	ANDA	ANDA078420	Westminster Pharmaceuticals, LLC	NABUMETONE	750 mg/1	100 TABLET in 1 BOTTLE, PLASTIC (69367-242-01)
69367-242-05	69367-242	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20190925	N/A	ANDA	ANDA078420	Westminster Pharmaceuticals, LLC	NABUMETONE	750 mg/1	500 TABLET in 1 BOTTLE, PLASTIC (69367-242-05)
63629-8508-1	63629-8508	HUMAN PRESCRIPTION DRUG	Nabumetone	Nabumetone	TABLET	ORAL	20190626	N/A	ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500 mg/1	100 TABLET in 1 BOTTLE (63629-8508-1)